LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study

Detalles Bibliográficos
Autores principales: Bersanelli, M., Giannarelli, D., Verzoni, E., Buti, S., De Giorgi, U., Clemente, A., Filetti, M., Di Napoli, M., Calvetti, L., Ermacora, P., Catino, A.M., Guaitoli, G., Bonomo, P., Mazzoni, F., Veccia, A., Grosso, F., Maruzzo, M., Rossi, E., Grossi, F., Procopio, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506488/
http://dx.doi.org/10.1016/j.annonc.2020.08.2323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506488/
http://dx.doi.org/10.1016/j.annonc.2020.08.2323

Ejemplares similares